FIELD: medicine.
SUBSTANCE: method involves dropping Ophthalmoferon at a dose of 2 drops twice a day into conjunctival cavity during 10-14 days.
EFFECT: enhanced effectiveness of treatment.
2 cl
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR TREATING THE CASES OF DRY EYE SYNDROME | 2004 |
|
RU2285511C2 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
AGENT FOR TREATMENT OF DRY EYE SYNDROME AS COMPLICATION AFTER OPHTHALMIC INFECTION | 2003 |
|
RU2239436C1 |
METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2581495C1 |
THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
Authors
Dates
2007-01-10—Published
2005-03-04—Filed